E
Edgewise Therapeutics, Inc.
EWTX · NASDAQ · Healthcare · 4.8B
Closing price
$39.06
-0.43% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
7.7×
Enterprise value / EBITDAEV/EBITDA
-23.9×
Free cash flow yieldFCF yield
-3.6%
Return on equityROE
-32.1%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.